Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. (TARS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
tars · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$100
Consensus
$84.00
+42.1% upside
Low
$68.00
Median: $84 · Last Close: $59.11
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$84.00
42.1% upside
High Target
$100
69.2%
Low Target
$68
15.0%
Current Price
$59.11
as of today
Based on analyst price targets, the TARS stock price prediction for the next 12 months ranges from $68 to $100. The consensus TARS price forecast of $84.00 implies 42.1% upside from the current price of $59.11.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $57.81 | ↓ 2.21% |
1-day model range: $57.51–$58.1. Peak: $58.1 (-2.21%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $97 | +63.9% |
| 2028 | $134 | +126.6% |
| 2029 | $165 | +178.8% |
| 2030 | $188 | +217.2% |
| 2031 | — | +243.5% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TARS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-25 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-05 | Guggenheim | Maintains | Buy→Buy |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-05 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-05-02 | Guggenheim | Maintains | Buy→Buy |
| 2025-03-06 | Jefferies | Maintains | Buy→Buy |
| 2025-02-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-26 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Tarsus Pharmaceuticals, Inc. (TARS) stock. Of the recent 45 rating actions, 0 were upgrades and 1 were downgrades. 9 analysts currently cover TARS.
Analyst Recommendation Trends
TARS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$696M
↓ 36.1% YoY
Revenue Next Year
$905M
↑ 29.9% YoY
EPS This Year
$-0.62
EPS Next Year
$3.03
↓ 590.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast TARS EPS of $-0.62 for the current fiscal year, based on estimates from 6 analysts. The TARS revenue forecast is $696M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TARS stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TARS price target is $84.00 (+42.1% upside), with an analyst consensus of Buy.
The TARS short-term stock prediction for tomorrow is $57.81 (-2.21%). The TARS stock price prediction for 2027 estimates an average of $97. The TARS stock prediction for 2030 projects a range of $177–$198.
Tarsus Pharmaceuticals, Inc. trades on NASDAQ under the ticker TARS. The TARS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
TARS forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month TARS price target is $84.00, with a high forecast of $100.00 and a low of $68.00. The median price target is shown in the chart above when available. This implies +42.1% potential upside from the current price of $59.11.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.